BAILEY DON M 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jul 6, 2022
Insider Transaction Report
Form 4
BAILEY DON M
Director
Transactions
- Award
Stock Option (right to buy)
2022-07-01+50,000→ 50,000 totalExercise: $1.57Exp: 2032-07-01→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.